← Open Payments lookup

THY LAM: Open Payments

NPI 1083277255 · VISTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$70,382 in 409 payments from 12 companies in 2025. Trend: 2023 $16,463 · 2024 $28,890 · 2025 $70,382

Speaker / faculty: $52,072Travel & lodging: $9,137Food & beverage: $8,628Consulting: $330Education: $215
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.143$64,921
Vanda Pharmaceuticals Inc.34$1,299
Alkermes, Inc.55$928
Otsuka America Pharmaceutical, Inc.48$793
Neurocrine BioSciences, Inc.30$637
E.R. Squibb & Sons, L.L.C.34$616
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)31$467
Lundbeck LLC15$252
Janssen Pharmaceuticals, Inc12$223
Otsuka Pharmaceutical Development & Commercialization, Inc.4$169

Products named: UZEDY, AUSTEDO XR, HETLIOZ, INGREZZA, ARISTADA, COBENFY, REXULTI, CAPLYTA.

Industry payments across CA — which companies pay providers there.